Postpartum thyroiditis medical therapy

Jump to navigation Jump to search

Postpartum thyroiditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Postpartum Thyroiditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Postpartum thyroiditis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Postpartum thyroiditis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Postpartum thyroiditis medical therapy

CDC on Postpartum thyroiditis medical therapy

Postpartum thyroiditis medical therapy in the news

Blogs on Postpartum thyroiditis medical therapy

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Postpartum thyroiditis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Patients of PPT with hyperthyroid phase are treated with beta blockers , whereas patients with hypothyroid phase are treated with levothyroxine LT4.

Medical Therapy

  • Pharmacological medical therapy is recommended among PPT with asymptomatic and symptomatic patients according to levels of TSH, phase of disease and planning of pregnancy.
  • In hyperthyroid phase radioiodine and antithyroid treatment is not useful because the increase in serum T3 and T4 is due to release of thyroid hormone in blood due to destruction of thyroid follicle rather than increased production.

Postpartum thyroiditis

  • Asymptomatic hyperthyroid phase:
  • No treatment required. Regular monitoring of FT3 and FT4 every 4 to 8 weeks to decide treatment of sever hyperthyroid phase.
  • Symptomatic hyperthyroid phase:
  • Preferred regimen (1): Propranolol 40 mg PO once daily; may increase to 120 mg once daily until their serum T3 and serum free T4 concentrations are normal
  • Preferred regimen (2):  Atenolol 25 mg PO once daily; may increase to 50 mg once daily after until their serum T3 and serum free T4 concentrations are normal
  • Preferred regimen (3):  Metoprolol 25 mg PO once daily; may increase to 50 mg once daily after until their serum T3 and serum free T4 concentrations are normal
  • Symptomatic hyperthyroid phase in breast feeding mothers:
  • Preferred regimen (1): Propranolol 40 mg PO once daily; may increase to 120 mg once daily until their serum T3 and serum free T4 concentrations are normal.
  • Alternate regimen (1):  Atenolol 25 mg PO once daily; may increase to 50 mg once daily after until their serum T3 and serum free T4 concentrations are normal.
  • Alternate regimen (2):  Metoprolol 25 mg PO once daily; may increase to 50 mg once daily after until their serum T3 and serum free T4 concentrations are normal.
  • Asymptomatic hypothyroid phase TSH above reference range, less than 10 mU/L not planning a subsequent pregnancy:
  • Preferred regimen (1): Regular monitoring of TSH every 4 to 8 weeks to decide treatment of sever hypothyroid phase.
  • Alternate regimen (1):  T4 (levothyroxine) 50 mcg PO once daily; may increase to 100 mcg once daily after until their serum TSH concentrations are normal.
  • Asymptomatic hypothyroid phase TSH above reference range, less than 10 mU/L planning a subsequent pregnancy:
  • Preferred regimen (1): T4 (levothyroxine) 50 mcg PO once daily; may increase to 100 mcg once daily after until their serum TSH concentrations are normal.
  • Alternate regimen (1): Regular monitoring of TSH every 4 to 8 weeks to decide treatment of sever hypothyroid phase.
  • Asymptomatic hypothyroid phase TSH above 10 mU/L:
  • Preferred regimen (1): T4 (levothyroxine) 50 mcg PO once daily; may increase to 100 mcg once daily after until their serum TSH concentrations are normal.
  • Symptomatic hypothyroid phase irrespective of TSH levels:
  • Preferred regimen (1): T4 (levothyroxine) 50 mcg PO once daily; may increase to 100 mcg once daily after until their serum TSH concentrations are normal.

References

Template:WH Template:WS